Puretech Health Plc Stock Alpha and Beta Analysis
| PRTC Stock | USD 16.64 0.35 2.06% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as PureTech Health PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in PureTech Health over a specified time horizon. Remember, high PureTech Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to PureTech Health's market risk premium analysis include:
Beta (0.36) | Alpha 0.0408 | Risk 2.72 | Sharpe Ratio (0.06) | Expected Return (0.16) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out PureTech Health Backtesting, PureTech Health Valuation, PureTech Health Correlation, PureTech Health Hype Analysis, PureTech Health Volatility, PureTech Health History and analyze PureTech Health Performance. PureTech Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. PureTech Health market risk premium is the additional return an investor will receive from holding PureTech Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PureTech Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate PureTech Health's performance over market.| α | 0.04 | β | -0.36 |
PureTech Health expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of PureTech Health's Buy-and-hold return. Our buy-and-hold chart shows how PureTech Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.PureTech Health Market Price Analysis
Market price analysis indicators help investors to evaluate how PureTech Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PureTech Health shares will generate the highest return on investment. By understating and applying PureTech Health stock market price indicators, traders can identify PureTech Health position entry and exit signals to maximize returns.
PureTech Health Return and Market Media
The median price of PureTech Health for the period between Thu, Oct 2, 2025 and Wed, Dec 31, 2025 is 17.03 with a coefficient of variation of 4.87. The daily time series for the period is distributed with a sample standard deviation of 0.84, arithmetic mean of 17.22, and mean deviation of 0.69. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | REG - PureTech Health PLC - Holding in Company - TradingView | 10/17/2025 |
2 | Will PureTech Health plc stock issue positive guidance - 2025 Sector Review Consistent Profit Trading Strategies - newser.com | 10/23/2025 |
3 | Can PureTech Health plc Depositary Receipt stock hit analyst price targets - July 2025 WrapUp Community Trade Idea Sharing - Fundao Cultural do Par | 10/27/2025 |
4 | Can PureTech Health plc Depositary Receipt stock outperform in 2025 bull market - Inflation Watch Real-Time Chart Pattern Alerts - newser.com | 11/04/2025 |
5 | Operating cash flow per share of PureTech Health PLC BER0VQ - TradingView | 12/03/2025 |
6 | PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone in Idiopathic Pulmonary Fibrosis | 12/08/2025 |
7 | How PureTech Health plc stock behaves under inflation pressure - July 2025 EndofMonth Weekly High Return Stock Forecasts - | 12/19/2025 |
About PureTech Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PureTech or other stocks. Alpha measures the amount that position in PureTech Health PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Dividend Yield | 1.14E-4 | 1.98E-4 | Price To Sales Ratio | 103.1 | 194.45 |
PureTech Health Upcoming Company Events
As portrayed in its financial statements, the presentation of PureTech Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PureTech Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of PureTech Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of PureTech Health. Please utilize our Beneish M Score to check the likelihood of PureTech Health's management manipulating its earnings.
| 26th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with PureTech Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out PureTech Health Backtesting, PureTech Health Valuation, PureTech Health Correlation, PureTech Health Hype Analysis, PureTech Health Volatility, PureTech Health History and analyze PureTech Health Performance. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
PureTech Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.